MedTrace Logo

Neurotoxic Symptoms in Adjuvant Chemotherapy in Patients With Colorectal Cancer

NCT02412683 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2016-09-07

No results posted yet for this study

Summary

Subgroups of patients with radically operated colorectal cancer can have a better prognosis by over six months are treated with chemotherapy. This beneficial effect may be enhanced somewhat by providing a combination of chemotherapy and the addition of oxaliplatin. It is known that this treatment additions increase the risk of neurotoxic side effects such as sensitivity to cold, numbness and tingling in hands or feet, muscle cramps, pain, taste disorders and swallowing difficulties.

The aim is to investigate how colorectal cancer patients with oxaliplatin adjuvant chemotherapy experience neurotoxic effects and if the experience of the symptoms change over time during treatment and how symptoms affect patients' daily lives and quality of life.

Conditions

  • Colorectal Neoplasms

Interventions

OTHER

oxaliplatin

Sponsors & Collaborators

  • Jenny Drott

    lead OTHER_GOV

Principal Investigators

  • Carina Bertero, RN,professor · Department of Health Sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02412683 on ClinicalTrials.gov